The stock market indices had a mixed session today, although at the end of the session they came on strong. The day started out with a pop to the upside for the Nasdaq 100, but the S&P 500 barely bounced. They barely came down in the morning, and the Nasdaq 100 held, although the S&P 500 made two lower lows. When the S&P 500 was not confirmed by the Nasdaq 100 by midday, they rallied, and rallied for the rest of the session. Not only that, the S&P 500 popped near 2270 at the close.

Net on the day, the Dow was down 42.87 at 19,899.29, about 88 points off the low. The S&P 500 was down 1.75 at 2269.00. The Nasdaq 100 was up 27.75 at 4964.95, just 3 points off the high.

Advance-declines were 16 to 13 negative on the New York Stock Exchange, and 17 to 12 negative on the Nasdaq. Up/down volume was 4 to 3 negative on New York, total volume 3.7 billion shares traded. The Nasdaq traded 1.75 billion shares and had a flat volume ratio.

TheTechTrader.com board was mixed. The Nasdaq general had a fairly decent participation. Priceline.com (PCLN) was up 16.41 to 1503.70, Alphabet Inc. (GOOG) up 7.12 to 794.02, Apple Inc. (AAPL) up 61 cents to 116.63, Amazon.com, Inc. (AMZN) 23.27 to 780.45, and Netflix, Inc. (NFLX) 2.40 to 131.81.

Baidu, Inc. (BIDU) jumped 5.51 to 177.47, Facebook, Inc. (FB) gained 1.98 to 120.67, but First Solar, Inc. (FSLR) gave back 29 cents to 33.88.

Tesla Motors, Inc. (TSLA) dropped 24 cents to 226.75.

The biotech stocks were mixed today, but Clovis Oncology Inc (CLVS) had a good day, up 1.66 to 46.33.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) was just above the zero line, closing up just a quarter to 36.53.

To the downside, Zumiez, Inc. (ZUMZ) had a difficult session, down 2.15 to 20.60. Argan, Inc. (AGX) was down 1.80 to 71.75, CoLucid Pharmaceuticals, Inc. (CLCD) down 2.75 to 32.95, NVIDIA Corporation (NVDA), continuing its recent weakness, 2.65 to 101.74, U.S. Concrete, Inc. (USCR) 1.75 to 63.50, United States Steel Corp. (X) 1.25 to 36.08, and XPO Logistics, Inc. (XPO) 1.43 to 43.71.

Checking TheTechTrader.com percent-gain leaderboard, EnteroMedics Inc. (ETRM) gained 1.88, or 90%, to 3.97, on nearly 20 million shares traded, 1,000% more volume than average.

Halozyme Therapeutics, Inc. (HALO) climbed 1.92, or 18%, to 12.61, on 16.8 million shares traded. Quantenna Communications, Inc. (QTNA) advanced 3.25, or 17%, to 22.88.

The Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG) ran 1.80, or 26%, to 8.74, on 77 million shares traded. The Direxion Daily Gold Miners Bull 3X ETF (NUGT) popped 1.56, or 18%, on 10.32, on 96.5 million shares traded.

Stepping back and reviewing the hourly chart patterns, the indices gapped up, ran up sharply on the Nasdaq 100, but not the S&P 500, and when they pulled back sharply late morning on the S&P 500, the Nasdaq 100 didn’t keep pace, and actually held the double-bottom support. That triggered a late-afternoon rally, that lasted into the afternoon and finished mixed, with the blue chips slightly low, but the Nasdaq 100 closed up on the day.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.